| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-07 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 2e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 1e-05 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |